508 related articles for article (PubMed ID: 19650155)
1. Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy.
Messinis L; Lyros E; Andrian V; Katsakiori P; Panagis G; Georgiou V; Papathanasopoulos P
Hum Psychopharmacol; 2009 Oct; 24(7):524-31. PubMed ID: 19650155
[TBL] [Abstract][Full Text] [Related]
2. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
[TBL] [Abstract][Full Text] [Related]
3. Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
Kakko J; von Wachenfeldt J; Svanborg KD; Lidström J; Barr CS; Heilig M
Biol Psychiatry; 2008 Jan; 63(2):172-7. PubMed ID: 17850768
[TBL] [Abstract][Full Text] [Related]
4. Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial.
Soyka M; Lieb M; Kagerer S; Zingg C; Koller G; Lehnert P; Limmer C; Kuefner H; Hennig-Fast K
J Clin Psychopharmacol; 2008 Dec; 28(6):699-703. PubMed ID: 19011441
[TBL] [Abstract][Full Text] [Related]
5. Treatment of heroin addicts using buprenorphine.
Kosten TR; Morgan C; Kleber HD
Am J Drug Alcohol Abuse; 1991 Jun; 17(2):119-28. PubMed ID: 1862786
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers.
Verdejo A; Toribio I; Orozco C; Puente KL; Pérez-García M
Drug Alcohol Depend; 2005 Jun; 78(3):283-8. PubMed ID: 15893159
[TBL] [Abstract][Full Text] [Related]
7. A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers.
Mintzer MZ; Correia CJ; Strain EC
Drug Alcohol Depend; 2004 May; 74(2):205-9. PubMed ID: 15099664
[TBL] [Abstract][Full Text] [Related]
8. An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence.
Rothman RB; Gorelick DA; Heishman SJ; Eichmiller PR; Hill BH; Norbeck J; Liberto JG
J Subst Abuse Treat; 2000 Apr; 18(3):277-81. PubMed ID: 10742642
[TBL] [Abstract][Full Text] [Related]
9. Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies.
Pirastu R; Fais R; Messina M; Bini V; Spiga S; Falconieri D; Diana M
Drug Alcohol Depend; 2006 Jun; 83(2):163-8. PubMed ID: 16343811
[TBL] [Abstract][Full Text] [Related]
10. Does naltrexone affect craving in abstinent opioid-dependent patients?
Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP
Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990
[TBL] [Abstract][Full Text] [Related]
11. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Collins ED; Kleber HD; Whittington RA; Heitler NE
JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of sublingual buprenorphine on brain responses to heroin-related cues in early-abstinent heroin addicts: an uncontrolled trial.
Mei W; Zhang JX; Xiao Z
Neuroscience; 2010 Oct; 170(3):808-15. PubMed ID: 20678551
[TBL] [Abstract][Full Text] [Related]
13. Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users.
Darke S; McDonald S; Kaye S; Torok M
Drug Alcohol Depend; 2012 Dec; 126(3):309-15. PubMed ID: 22726911
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
Loeber S; Kniest A; Diehl A; Mann K; Croissant B
Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
[TBL] [Abstract][Full Text] [Related]
15. Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial.
Schottenfeld RS; Chawarski MC; Mazlan M
Lancet; 2008 Jun; 371(9631):2192-200. PubMed ID: 18586174
[TBL] [Abstract][Full Text] [Related]
16. Quality of life among heroin users on buprenorphine versus methadone maintenance.
Ponizovsky AM; Grinshpoon A
Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
[TBL] [Abstract][Full Text] [Related]
17. Role of buprenorphine in the management of heroin addiction.
Sung S; Conry JM
Ann Pharmacother; 2006 Mar; 40(3):501-5. PubMed ID: 16434562
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the discriminative stimulus effects of buprenorphine in pigeons.
Galici R; Brandt MR; France CP
Psychopharmacology (Berl); 2002 Mar; 160(2):132-9. PubMed ID: 11875630
[TBL] [Abstract][Full Text] [Related]
19. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
Hulse GK; Morris N; Arnold-Reed D; Tait RJ
Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
[TBL] [Abstract][Full Text] [Related]
20. Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence.
White J; Bell J; Saunders JB; Williamson P; Makowska M; Farquharson A; Beebe KL
Drug Alcohol Depend; 2009 Jul; 103(1-2):37-43. PubMed ID: 19403243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
